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ORIGINAL ARTICLE
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BACKGROUND Once in the pulmonary alveoli, Mycobacterium tuberculosis (Mtb) enters into contact with alveolar macrophages 
and dendritic cells (DCs). DCs represent the link between the innate and adaptive immune system owing to their capacity to be 
both a sentinel and an orchestrator of the antigen-specific immune responses against Mtb. The effect that the virulence of Mtb 
has on the interaction between the bacilli and human DCs has not been fully explored.
OBJECTIVE To evaluate the effect of Mtb virulence on human monocyte-derived DCs.
METHODS We exposed human monocyte-derived DCs to Mtb clinical strains (isolated from an epidemiological Mtb diversity 
study in Mexico) bearing different degrees of virulence and evaluated the capacity of DCs to internalise the bacilli, control 
intracellular growth, engage cell death pathways, express markers for activation and antigen presentation, and expand to stimulate 
autologous CD4+ T cells proliferation.
FINDINGS In the case of the hypervirulent Mtb strain (Phenotype 1, strain 9005186, lineage 3), we report that DCs internalise 
and neutralise intracellular growth of the bacilli, undergo low rates of apoptosis, and contribute poorly to T-cell expansion, as 
compared to the H37Rv reference strain. In the case of the hypovirulent Mtb strain (Phenotype 4, strain 9985449, lineage 4), 
although DCs internalise and preclude proliferation of the bacilli, the DCs also display a high level of apoptosis, massive levels of 
apoptosis that prevent them from maintaining autologous CD4+ T cells in a co-culture system, as compared to H37Rv.
MAIN CONCLUSIONS Our findings suggest that variability in virulence among Mtb clinical strains affects the capacity of DCs to 
respond to pathogenic challenge and mount an immune response against it, highlighting important parallels to studies previously 
done in mouse models.
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Tuberculosis (TB) remains a challenging infectious 
disease and was rated by the World Health Organization 
in 2017 as one of the top ten causes of death worldwide. 
In 2019, TB was responsible for more deaths than HIV 
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and malaria, accounting for 1.6 million deaths world-
wide.(1) Therefore, there is a need to better understand 
the interaction between Mycobacterium tuberculosis 
(Mtb) and host cells in order to design better preventive 
and therapeutic strategies.
TB is mainly transmitted among humans when Mtb 
is inhaled via the aerosol route.(2) Once in the pulmonary 
alveoli, Mtb enters into contact with alveolar macro-
phages and dendritic cells (DCs), which are the domi-
nant cell targets for this pathogen.(3) In particular, DCs 
represent the link between the innate and adaptive im-
mune systems due to their capacity to act as both a “sen-
tinel” and an “orchestrator” of the antigen-specific im-
mune responses against the bacilli. As a “sentinel”, DCs 
patrol peripheral sites and are capable of recognising and 
internalising microorganisms that invade the mucosal 
barrier.(4) As an “orchestrator”, DCs efficiently acquire 
and process Mtb-specific antigens at the site of infec-
tion, and then traffic them to the lymph nodes, where T-
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cell priming occurs. There is a keen interest in the field 
to investigate in detail how Mtb interacts with DCs, and 
how this interaction can be modulated for the efficient 
elimination of Mtb infection.
Upon encountering and internalising a pathogen, 
DCs must activate an intracellular microbicidal environ-
ment to restrict pathogen growth and spread.(5) In vitro 
studies in monocyte-derived dendritic cells (MDDCs) 
suggest low levels of bacterial replication within these 
cells.(6) While Mtb is known to affect cell death of in-
fected DCs,(7,8) the pathways related to this process have 
not been extensively studied in DCs within the context 
of TB. Upon neutralising the intracellular pathogen, 
DCs undergo a maturation process that allows them to 
process antigens derived from the pathogen, and subse-
quently relay this information to naïve T cells in the form 
of antigen presentation. To counteract this process, Mtb 
impairs DC maturation, reduces the capacity of DCs to 
secrete IL-12, and inhibits the ability of DCs to stimulate 
T-cell proliferation.(9,10,11) However, further studies are 
required to understand the degree of the effect of Mtb 
virulence on the capacity of the bacteria to inhibit DCs. 
This is precisely the focus of this study.
The relationship between the virulence of Mtb 
strains and their transmissibility in humans, as well as 
its consequences on the quality of the host immune re-
sponse, has been studied, among others, by Marquina-
Castillo et al.(12). They conducted a 10-year population-
based prospective study of pulmonary TB in Southern 
Mexico by performing an in-depth analysis of the epi-
demiological and clinical data of household contacts 
of TB patients. The authors selected a panel of isolates 
representing clinical and epidemiological diversity 
in the population of Mtb strains found in Mexico and 
tested them in two mouse models. Based on strain viru-
lence, immune response (defined by cytokine expres-
sion), and transmissibility, four phenotypes were identi-
fied. The strains representing the two extremes, from 
hypervirulence to hypovirulence, were Phenotype 1 
(strain 9005186, lineage 3, family EAI) and Phenotype 
4 (strain 9985449, lineage 4, family Haarlem), respec-
tively. On the one hand, Phenotype 1 (Ph1) was highly 
transmissible; it grew rapidly in the lung and caused 
high mortality rates in mice along with significantly 
more pneumonic areas, as compared to the H37Rv ref-
erence strain. In addition, Ph1 induced a poor protective 
immune response in the host. On the other hand, Pheno-
type 4 (Ph4) exhibited a long survival index, low bacil-
lary load, and little pneumonia. Moreover, Ph4 induced 
a delayed acquired protective immune response.(13) The 
human leukocyte response against these Mtb clinical 
isolate strains is still poorly understood.
Here, we focused our investigation on the interac-
tion of Mtb clinical isolates Ph1 and Ph4 with human 
DCs. Altogether, our study showed that Mtb virulence 
has an important effect on the interaction with human 
DCs and the capacity of those DCs to then stimulate to 
T lymphocytes expansion, suggesting that these clinical 
isolate strains are optimal candidates for the prospective 
identification of Mtb genes associated with virulence 
and human immunogenicity.
MATERIALS AND METHODS
Human blood peripheral mononuclear cells, MD-
DCs and T lymphocytes - Mononuclear cells were iso-
lated from buffy coats provided by the State Blood 
Transfusion Center of Zacatecas, SSA (Guadalupe, Zac., 
Mexico) by density gradient using Ficoll-Paque PLUS 
(GE Healthcare, UK). The donors were healthy individu-
als complying with the following criteria: 18-55 years 
old, minimum weight of 50 kg, fasting conditions for 
at least 8 h, and with no history of Hepatitis type B or 
C, HIV/AIDS, syphilis, organ transplants, epilepsy, tu-
berculosis, cardiovascular disease, or cancer. Exclusion 
criteria included recreational drug use, mental disease, 
women who were pregnant or lactating, tattoos or skin 
perforations (12 months previous to the donation), his-
tory of diabetes, surgery, mononucleosis, toxoplasmosis 
or meningitis (in the last six months), having received 
vaccines (in the last 28 days), alcohol or narcotics use (in 
the last 12 h). Different sets of individuals were used for 
the distinct parameters evaluated in the present protocol. 
The number of individuals evaluated in each assay is an-
notated in the corresponding figure legend. Whole blood 
from individuals positive for tuberculin was used only 
for T-cell proliferation assays.
In order to generate MDDCs, mononuclear cells (5 
× 106) were seeded in a 75 cm2 flask using RPMI-1640 
medium supplemented with 10% foetal calf serum (FCS) 
(Gibco Life Technologies, USA), 1% pyruvate (Sigma Al-
drich, USA), 0.1% 2-beta-mercaptoethanol (Gibco Life 
Technologies, USA), recombinant IL-4 (15 ng/mL) (Pe-
protech Inc., USA), and granulocyte macrophage colony 
stimulating factor (GM-CSF, 200 ng/mL) (GRAMAL, 
Probiomed Lab, Mexico), and cultured at 37ºC in a hu-
midified atmosphere at 5% CO2. At days 3 and 5, the cells 
were additionally supplemented with IL-4 and GM-CSF. 
At day 7, MDDCs were collected by centrifugation and 
used for functional analyses. Alternatively, mononuclear 
cells isolated from healthy volunteers with positive tuber-
culin tests (range of 15 to 25 mm) were used to generate 
MDDCs and to purify CD4+ T cells by a magnetic bead 
approach using the CD4+ negative selection kit (Miltenyi, 
USA) according to manufacturer’s instructions.
Mtb strains, culture and storage - All manipula-
tions with the Mtb strains were performed in a dedi-
cated BSL-3 laboratory. The Mtb strain H37Rv was 
used in order to establish an experimental reference for 
the comparative analyses done with the clinical isolate 
strains Ph1 (highly virulent, with no induction of pro-
tective immune response in mice) and Ph4 (less viru-
lent, provoking a protective adaptive immune response).
(12) The strain Ph1, for spoligotyping, belongs to the fam-
ily EAI and it is susceptible to all the first-line antibiot-
ics used for TB treatment, while strain Ph4 belongs to 
the Haarlem family and is streptomycin-monoresistant. 
All strains were grown in Middlebrook 7H9 medium 
(BD-Diagnostic Systems, USA) supplemented with 
10% Middlebrook Oleic Albumin Dextrose Catalase 
Growth Supplement (OADC) (BD-Diagnostic Systems, 
USA). Strains were grown to reach exponential phase, 
and culture concentrations were measured by measur-
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ing optical density at 600 nm. Bacterial aliquots were 
stored at -80ºC until their use. Bacillary viability was 
tested using the colony forming unit (CFU) assay, grow-
ing serial dilutions in 7H10 agar plates (BD-Diagnostic 
Systems, USA) supplemented with 10% OADC (BD-
Diagnostic Systems, USA) for 14 and 21 days.
Internalisation of Mtb and infection of MDDCs - Bac-
terial aliquots (H37Rv, Ph1, and Ph4) were thawed at room 
temperature, and the bacterial aggregate declumping was 
achieved by vortexing with borosilicate beads for 5 min 
and centrifuging at 2040 × g for 5 min. MDDC infection 
was performed at a multiplicity of infection (MOI) of 5 
(5 bacteria to 1 cell). At 2 h post-infection (hpi), MDDCs 
were washed with RPMI-1640 medium to remove non-
internalised bacteria. At 24 hpi, MDDCs were recollected 
by centrifugation and fixed with 4% paraformaldehyde 
(PFA) for 30 min at room temperature. In order to evalu-
ate internalisation of Mtb strains, the fixed MDDCs were 
centrifuged in pretreated slides (Biocare Medical, Con-
cord CA, USA) using a Cytocentrifuge (Wescor Cytopro 
7620, USA), and Ziehl-Neelsen staining was performed to 
identify the bacilli associated/within cells. The percent-
age of MDDCs with at least one associated bacterium was 
calculated after counting at least 100 MDDCs/sample in 
high power fields using a Carl Zeiss inverted Axiovert 
M-200 microscope (Zeiss, Germany).
Mtb intracellular growth in human MDDCs - The 
bacterial strains were cultured at 37ºC in Middlebrook 
7H9 medium supplemented with 10% OADC and 0.05% 
Tween-80 (Sigma-Aldrich, USA). During exponential 
growth, the bacteria were centrifuged (2000 × g) for 15 
min and resuspended in 1× phosphate buffered saline 
(PBS). Clumps were dissociated by passages through a 
26-G needle, and then resuspended in RPMI-1640 me-
dium containing 10% FBS. The mycobacterial concen-
tration was determined by measuring optical density at 
600 nm (OD600). To test the intracellular growth capac-
ity of these strains, MDDCs were collected at day 7 of 
culture and seeded in 24-well plates at a density of 5 × 
105 cells per well. These cells were then infected with 
each Mtb strain individually at a multiplicity of infection 
(MOI) of 0.2 bacteria per cell in RPMI-1640 medium 
with 10% FBS for 4 h. Cells were then washed twice 
with 1× PBS before addition of RPMI-1640/10% FBS. At 
the indicated time points, the cells were lysed in a 0.1% 
Triton (Sigma-Aldrich, USA) lysing solution. Serial di-
lutions of the resulting bacterial suspension were plated 
on Middlebrook 7H11 solid agar supplemented with 10% 
OADC (BD-Diagnostic Systems, USA) and incubated 
for 14-21 days at 37ºC for CFU scoring.
Cell-death assessment of MDDCs infected with Mtb 
strains - To evaluate apoptosis and necrosis, we anal-
ysed MDDCs at day 7 of differentiation using the FITC 
Annexin V Apoptosis Detection Kit II (BD Biosciences, 
USA), according to the manufacturer’s instructions. 
Briefly, MDDCs were infected with each Mtb strain in-
dividually at a MOI of 5 in RPMI-1640 medium with 
10% FBS for 4 h. MDDCs were then washed twice with 
1× PBS before addition of RPMI-1640/10% FBS. After 
24 h, MDDCs were washed twice with cold PBS and 
resuspended in 1× binding buffer, stained with 5 µL of 
Annexin V and 5 µL of Propidium Iodide, and gently 
vortexed and incubated for 15 min at room temperature, 
protected from light. MDDCs were then and washed us-
ing PBS and resuspended in 4% PFA for 30 min at room 
temperature for fixation. Finally, the viability status of 
all MDDC populations was acquired using the FACS 
Canto II cytometer (BD Biosciences, USA). For data 
analysis, Flow Jo VX (Tristar, USA) was used.
T-cell proliferation assay - The ability of Mtb-in-
fected MDDCs to stimulate CD4+ T cells was assessed 
using an autologous co-culture system, as previously 
Fig. 1: virulence of Mycobacterium tuberculosis (Mtb) strains does 
not affect recognition/internalisation by human monocyte-derived 
dendritic cells (MDDCs). Human monocytes were differentiated into 
MDDCs until day 7. (A) Percentage of Mtb bacilli internalised by MD-
DCs after infection with the Mtb experimental H37Rv strain (white) 
or clinical isolate strains Ph1 (black) and Ph4 (grey). Results were 
analysed using Kruskal-Wallis tests. (B) Categorisation of infected 
MDDCs according to the number of bacilli (1-5, white; 6-10, black; 
> 10, grey) internalised per cell, illustrated as percentage of infected 
MDDCs. Each bar represents mean ± SEM of four independent donors. 
Results were analysed using two-way analysis of variance (ANOVA).
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described.(14) Briefly, autologous CD4+ T cells (the re-
sponders) were freshly isolated and purified from 
healthy donors positive for the tuberculin test on the 
day that the co-culture was initiated. A total of 1.5 × 104 
5-(and 6)-Carboxyfluorescein diacetate succinimidyl 
ester (CFSE) stained CD4+ T cells (responder cells) were 
added to each well in 200 μL complete media on round-
ed-bottom, 96-well plates (BD, Pharmingen, USA). Au-
tologous MDDCs (the stimulators) were differentiated 
until day 6 and pulsed for 24 h with LPS (100 ng/mL) 
(Sigma, Germany). Later, MDDCs were infected with 
each Mtb strain individually at a MOI of 0.2 in RPMI-
1640 medium with 10% FBS for 4 h, washed twice with 
1× PBS, harvested, and added to the responder cells at 
a ratio (stimulator:responder) of 1:2.5, 1:5, 1:10, or 1:20. 
As a control for the response to Mtb antigens, a group of 
non-infected MDDCs were grown until day 6 and were 
then pulsed for 24 h with a peptide corresponding to the 
partial sequence of the Mtb early secretory antigenic 
target (ESAT-6) protein (20 μg/mL) for 24 h. Of note, 
the partial ESAT-6 protein a peptide with the sequence 
H2N-LNNALQNLARTISEAG-COOH was synthesised 
at Fundación Instituto de Inmunología de Colombia, 
Bogotá Colombia. After six days of culture in 5% CO2 
at 37ºC, the cells were harvested, stained, and gated for 
CD3 and CD4 positivity, and then analysed for dilution 
of the CFSE intensity by flow cytometry.
Statistical analyses - The corresponding statistical 
analysis is annotated in each figure legend. Data was 
compared using two-way ANOVA analysis with Bonfer-
roni’s post-hoc test for internalisation index, Wilcoxon 
analysis for CFU, while comparison inside the groups 
was performed with the Kruskal-Wallis test and Dunn’s 
post-test assuming non-normally distributed data for all 
the other analysed variables. Statistical analysis was per-
formed with GraphPad Prism software v.5.0 (San Diego, 
CA, USA). P ≤ 0.05 was considered as the level of statis-
tical significance.
Ethical considerations - The present protocol was re-
viewed and authorised by the National Research Commit-
tee of Instituto Mexicano del Seguro Social (The Mexi-
can Institute of Social Security, IMSS), that includes a 
subcommittee for ethical approval (agreement number 
R-2014-785-042). Informed consent was obtained from all 
individual participants included in the study.
RESULTS
Virulence of Mtb strains does not affect recognition/
internalisation by human MDDCs - In order to assess 
whether the virulence of the Mtb clinical isolates Ph1 
and Ph4 affect their capacity to be recognised/inter-
nalised by human MDDCs, we infected MDDCs with 
each bacterial strain, and the bacillary load was de-
termined by Ziehl-Neelsen staining. Our results show 
only a tendency towards a higher recognition/internali-
sation of low virulence strains compared to the refer-
ence H37Rv strain (Fig. 1A). This was confirmed by an 
analysis of the number of bacilli bound/internalised per 
MDDC, which yielded no difference among any clinical 
isolate compared to H37Rv (Fig. 1B). Therefore, these 
results suggest that variations in virulence do not sig-
nificantly affect the capacity of Mtb clinical strains to be 
recognised or internalised by MDDCs.
MDDCs control the intracellular growth of the Mtb 
clinical strains independent of virulence - In order to 
investigate whether the virulence of Mtb strains modu-
lates their capacity to proliferate in human MDDCs, 
we performed CFU assays. After 4 hpi (day 0), we con-
firmed there was no significant difference in the bacte-
rial charge in MDDCs infected with the different Mtb 
strains (Fig. 2). More specifically, we observed that MD-
DCs were able to control the intracellular growth of both 
Ph1 and Ph4 Mtb clinical strains after 120 hpi (day 5). 
However, at day 5, we did observe a higher inhibition of 
growth of the Ph1 strain compared to the reference strain 
(Fig. 2). Altogether, the results suggest that these Mtb 
clinical isolate strains fail to colonise human MDDCs, 
and that the difference in virulence among these strains 
does not play a role in this process.
Mtb clinical strain bearing low virulence leads 
to high levels of apoptosis in MDDCs - We examined 
whether the difference in virulence among the Mtb clini-
cal isolate strains affects the mode of cell death in infect-
ed MDDCs. Flow cytometry revealed that at 24 hpi, the 
strain with lower virulence (Ph4) induced more apopto-
sis in MDDCs compared to the other Mtb strains and to 
the uninfected cells (Fig. 3A-C). As shown in Fig. 3C, 
the virulence among the Mtb strains does not signifi-
cantly affect the induction of necrosis in MDDCs. Over-
all, these results show that the hypovirulent Mtb clinical 
Fig. 2: human monocyte-derived dendritic cells (MDDCs) control the 
intracellular growth of the Mycobacterium tuberculosis (Mtb) clini-
cal strains independent of virulence. MDDCs were infected with the 
Mtb experimental strain H37Rv (black circles) the Ph1 clinical isolate 
strain (white squares), or the Ph4 clinical isolate strain (black dia-
monds). The intracellular growth of the bacteria was determined at 
4 h (day 0) and 120 h (day 5) post-infection, as measured by colony 
forming unit (CFU) assays. Vertical scatter plots show the number 
of CFU per mL with each symbol representing a single donor run in 
triplicate, n = 5 different donors. Data were analysed with two-way 
analysis of variance (ANOVA) for repeated measures and the Bonfer-
roni post-hoc test was applied. Bars represent median and interquar-
tile range for five different donors. **p ˂ 0.01.
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isolate strain (Ph4) differs considerably in its capacity to 
induce apoptosis, but not necrosis, in infected MDDCs 
when compared to the hypervirulent strain (Ph1) and the 
experimental H37Rv reference strain.
Virulence of Mtb strains does not affect the activa-
tion of MDDCs - In order to assess whether the virulence 
of the Mtb clinical isolate strains affects the activation 
of human DCs, we evaluated the expression of cell sur-
face markers during infection by flow cytometry. As ex-
pected, MDDCs infected with any Mtb strain displayed 
significantly higher levels (albeit only a tendency for 
H37Rv) of the activation marker CD83, as compared to 
uninfected cells. Yet, there were no differences observed 
between the Mtb clinical isolate strains or compared to 
the reference H37Rv strain (Fig. 4A). In addition, we as-
sessed the expression levels of receptors that are impor-
tant for antigen presentation, such as CD86 and HLA-DR. 
Although MDDCs infected with the clinical isolate bear-
ing low virulence (Ph4) displayed higher levels of CD86 
compared to uninfected cells, we noticed there were no 
significant differences detected among all the infected 
groups (Fig. 4B). The same was true for the expression 
levels of HLA-DR among all the infected groups, al-
though there was a tendency for higher expression com-
pared to uninfected cells (Fig. 4C). Altogether, these re-
sults suggest that the difference in virulence among the 
Mtb strains does not affect the activation of MDDCs.
Virulence of Mtb strains affects the capacity of 
MDDCs to activate CD4+ T cells - In order to evaluate 
whether the virulence of the Mtb clinical isolate strains 
modulates the capacity of MDDCs to activate T lym-
phocytes, we set up an autologous co-culture system to 
evaluate T-cell proliferation based on the dilution of the 
CFSE dye, as measured by flow cytometry. As expect-
ed, T cells that were co-cultured with uninfected MD-
DCs did not proliferate, as measured by the undiluted 
CFSE dye (Fig. 5A-B). By contrast, we observed T-cell 
proliferation with MDDCs pulsed with the ESAT-6 pep-
tide, which served as positive control, at any tested ratio 
(MDDC:T cell), confirming the presence of an antimy-
cobacterial immune response in healthy donors positive 
for the tuberculin test (Fig. 5C). Likewise, we noticed 
that MDDCs infected with the H37Rv reference strain 
were also capable of inducing robust T-cell proliferation 
(Fig. 5D). However, comparison of MDDCs infected 
with the different Mtb clinical isolates resulted in strik-
ing differences. On the one hand, MDDCs infected with 
the clinical isolate bearing low virulence (Ph4) were not 
able to prevent cell death of autologous T cells, as the 
co-cultures did not remain viable for the entire six day 
co-culture period (data not shown). On the other hand, 
MDDCs infected with the clinical isolate bearing high 
virulence (Ph1) were capable of inducing T-cell prolif-
eration, but less efficiently than MDDCs infected with 
Fig. 3: the Mycobacterium tuberculosis (Mtb) clinical strain bearing low virulence induces high levels of apoptosis in monocyte-derived dendritic 
cells (MDDCs). MDDCs were infected for 24 h with the Mtb experimental strain H37Rv, clinical isolate Ph1, clinical isolate Ph4, or uninfected 
control. The MDDCs were then stained using the FITC Annexin V Apoptosis Detection Kit II. (A) Representative dot plot for the gating strategy 
to assess MDDC cell death in non-infected, H37Rv-infected, Ph1-infected, and Ph4-infected MDDCs. The plots are illustrative of cell death 
measurements as analysed by flow cytometry. The amount of MDDC cell death due to (B) apoptosis (propidium iodide-/Annexin V+ cells) or (C) 
necrosis (propidium iodide+ cells) was quantified. Analysis for comparison among groups was performed in parts B and C using one-way analysis 
of variance (ANOVA). For the apoptosis data, Tukey s´ post-hoc test was performed. Bars represent mean ± SD for six different donors. *p ˂ 0.05.
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the H37Rv reference strain (Fig. 5A,D). These results 
were consistent for the five independent tuberculin-
positive donors tested in the antigen presentation assays, 
even when there were not statistic differences between 
the rates of proliferation induced by Ph1 compared to 
H37Rv. Collectively, these results suggest that the viru-
lence difference among the Mtb clinical strains is an im-
portant factor that can affect antigen presentation.
DISCUSSION
Most of the information about Mtb strain varia-
tion and immunopathology derives from experimen-
tal animal models.(13) Yet, this information cannot be 
extrapolated directly to human TB infection, and thus 
highlights the need to study Mtb strain variation using 
human leukocytes. In the present study, we investigated 
whether Mtb clinical isolates obtained from a prospec-
tive population-based study of pulmonary TB patients in 
Southern Mexico, whose virulence varied dramatically 
from high (Ph1) to low (Ph4) in a mouse model,(12) dif-
fer in their interaction with human DCs in comparison 
to the standard experimental strain H37Rv. We believe 
this study makes the following contributions in advanc-
ing our understanding of how these Mtb clinical isolates 
differ in their interaction with human DCs.
First, we showed that the Ph1 hypervirulent strain 
diminishes the capacity of human DCs to activate au-
tologous CD4+ T cells. Compared to DCs infected with 
H37Rv, Ph1-infected DCs displayed a poor capacity to 
induce proliferation of autologous T cells in our in vi-
tro co-cultures. This is not due to a deficiency in DCs 
to recognise or internalize the Ph1 strain in comparison 
to H37Rv. Additionally, judging from the induction of 
antigen presenting molecules (e.g. HLA-DR, CD86) and 
cell death pathways (e.g. apoptosis, necrosis), we can 
rule out a problem with the ability of the Ph1 strain to 
activate DCs. Rather, we believe that the diminished 
capacity of Ph1-infected DCs to activate autologous 
T cells may be due to their inability to colonise these 
APCs. Based on our CFU assays, we determined that 
Ph1 failed to achieve a significant level of intracellu-
lar growth in human DCs. Therefore, we can infer that 
the Ph1-infected DCs may have less antigenic material 
available to present and activate naïve T cells. This is 
in contrast to the results obtained in the study by Mar-
quina-Castillo et al.(12) conducted in a mouse model. In 
their study, the Ph1 strain grew rapidly in the lung and 
peaked at 21 dpi, exhibiting a bacterial burden (via CFU 
readings) twice as high in comparison to those mice in-
fected with the H37Rv strain.(12) We infer this phenotype 
is likely due to the capacity of the Ph1 strain to colonise 
and grow within other leukocytes besides DCs, because, 
compared to H37Rv, the Ph1 strain displays similar in 
vitro phenotypes in terms of cord formation, growth 
curves, and response to hydrogen peroxide exposure.(12) 
However, the authors did not examine the type of mu-
rine leukocytes serving as reservoirs for the bacteria. As 
previously reported, DCs exhibit a non-permissible phe-
notype against Mtb intracellular growth,(6) and this char-
acteristic is not influenced by the degree of virulence 
as we are showing in this study. Therefore, our results 
suggest that the Ph1 strain may have a better capacity to 
colonise macrophages in contrast to DCs.
Nevertheless, our observation that Ph1-infected DCs 
do not optimally activate autologous T cells is in line with 
the main finding in the study conducted by Marquina-
Castillo et al.,(12) which concluded that the Ph1 strain does 
not induce a protective immune response in a mouse 
model, such as the one promoted by the H37Rv strain. 
Indeed, infection of mice with the Ph1 strain was charac-
terised by a delayed IFNγ expression, which is indicative 
of poor activation of Th1 cells.(12) Infection of mice with 
other hypervirulent Mtb strains, such as those belonging 
to the W-Beijing lineage, also results in a poor protec-
tive Th1-driven immune response distinguished by the 
low and temporal expression of IFNγ, TNFα, and iNOS.
(15,16) Suboptimal antigen presentation has been shown to 
contribute to the virulence of Mtb in an in vivo mouse 
model.(17) Moreover, DCs generated from monocytes after 
Type I IFN exposure (IFN-DCs) highly resemble natu-
rally occurring DCs induced in vivo, for example, in a 
chronic infection context.(18) In active TB patients, IFN-
DCs showed a diminished capacity to induce Ag-specific 
T-cell responses against Mtb.(19) Collectively, our results 
argue that the interaction of the Ph1 hypervirulent strain 
with human DCs differs from that of H37Rv, resulting in 
a lower capacity for these antigen-presenting cells to opti-
mally activate an adaptive immune response.
The second key contribution of our study is the dem-
onstration that the Ph4 hypovirulent strain induces apop-
tosis in human MDDCs, preventing them from support-
ing an autologous co-culture system with T lymphocytes. 
Fig. 4: virulence of Mycobacterium tuberculosis (Mtb) strains does not affect the activation of monocyte-derived dendritic cells (MDDCs). MD-
DCs were infected with H37Rv (light grey), clinical isolate Ph1 (black), clinical isolate Ph4 (dark grey), or left uninfected as a control (white). 
After 24 h, MDDCs were harvested and stained for activation markers, as assessed by flow cytometry. Bar graphs show the fluorescent intensity 
(MFI) (mean ± SEM) for cell-surface expression of (A) CD83, (B) CD86, and (C) HLA-DR. Intragroup comparisons were performed with a 
Kruskal-Wallis test followed by Dunn’s multiple comparison post-test. For each group, n = 4 different donors. *p ˂ 0.05.
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Similar to the cells infected with H37Rv, MDDCs were 
able to recognise, internalise, and control the intracellular 
growth of the Ph4 strain. However, MDDCs infected with 
this hypovirulent strain underwent rapid and massive 
levels of apoptosis, as compared to the other Mtb strains. 
These results suggest that less virulent Mtb strains can 
induce apoptosis in DCs, as well as macrophages, and in 
this manner, become a source of antigen for other anti-
gen-presenting cells to pick up and promote an efficient 
adaptive immune response, as postulated previously.(7,20) 
Interestingly, while the Ph4 strain did not differ in its ca-
pacity to activate MDDCs in terms of the up-regulation 
of cell surface receptors involved in antigen presentation 
(albeit always displaying the highest tendency among the 
tested strains), MDDCs infected with this strain were not 
able to support the established autologous co-culture sys-
tem with CD4+ T cells. In the context of TB, infected mi-
gratory DCs are poor antigen-presenting cells,(21) which 
suggests that infected cells have a mechanism to transfer 
antigen to uninfected cells so that uninfected cells could 
prime CD4+ T cells. In vivo studies demonstrated that mi-
gratory DCs must collaborate with one or more resident 
Fig. 5: virulence of Mycobacterium tuberculosis (Mtb) strains affects the capacity of monocyte-derived dendritic cells (MDDCs) to activate 
CD4+ T cells. MDDCs were activated with LPS and then infected with the different Mtb strains (or left uninfected as a control). MDDCs were 
added at different ratios to autologous CD4+ T cells that were previously labelled with CFSE dye. After culturing for six days, cells were har-
vested and stained for flow cytometry analysis. (A) Gating strategy to select cells by size and granularity, and double positivity for the receptors 
CD3 (PE-A) and CD4 (APC-A) to specifically determine the T-cell population. Representative histograms showing the MFI for the CFSE dye 
in the T-cell populations co-cultured with (B) uninfected MDDCs (negative control), (C) MDDCs pulsed with the peptide from ESAT-6 (control 
for response to Mtb antigens), (D) MDDCs infected with the H37Rv strain, and (E) MDDCs infected with the Ph1 strain. The cells were plated 
at a ratio of 1 MDDC to 10 CD4+ T lymphocytes.
DCs to successfully prime CD4+ T cells.(22,23) Cultured 
DCs and macrophages release multiple Mtb protein anti-
gens into the extracellular medium that can be taken up, 
processed, and presented to CD4+ T cells by uninfected 
DCs.(23) This form of antigen transfer occurs without 
transfer of the pathogen itself, providing a mechanism 
for host cells to bypass the inhibitory effects of Mtb on 
antigen presentation and allow for effective priming of 
antigen-specific CD4+ T cells. We inferred that MDDCs 
infected with the Ph4 strain become the source of my-
cobacterial antigens for uninfected bystander antigen-
presenting cells, which may consequently activate an ef-
ficient T-cell response. Moreover, we believe that these 
results are in line with the characterisation performed in 
the mouse model by Marquina-Castillo and colleagues.
(12) Indeed, the authors determined that infection of mice 
with the Ph4 strain culminated in an increased surviv-
al rate of the mice in comparison to infection with the 
H37Rv strain. This was also correlated with a better pro-
tective acquired immune response characterised by high 
and sustained (albeit delayed) IFNγ expression, and early 
high levels of TNFα expression.(12)
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It remains to be determined what signalling path-
ways promote the rapid and high levels of apoptosis 
triggered by the Ph4 strain in MDDCs. In the context of 
murine: bone marrow-derived-dendritic cells (BMDC) 
for example it was demonstrated that Mtb induces cas-
pase-1/11-independent apoptosis but not necrosis.(7) In 
the context of macrophages, avirulent Mtb strains in-
duce strong expression of prostaglandin-endoperoxide 
synthase 2 (PTGS2), which consequently leads to high 
rates of apoptosis-promoting prostaglandin E2 (PGE2) 
production.(20) Lipoxin A4 (LXA4) is known to inhibit 
PTGS2 and PGE2, leading to an increase in necrosis in-
stead of apoptosis, which is common in macrophages in-
fected by virulent Mtb strains.(5) Altogether, our results 
argue that the interaction of the Ph4 hypovirulent strain 
with human DCs greatly differs from that of the H37Rv 
strain, resulting in rapid and massive rates of apoptosis 
that may facilitate the acquisition of antigenic material, 
thus leading hypothetically towards an efficient activa-
tion of the adaptive immune response.
In conclusion, this study represents the first prospec-
tive assessment of the human leukocyte response to the 
Mtb strains endemic in Southern Mexico that vary in 
virulence and transmission as previously assessed in 
mouse models. In general, our findings in human DCs 
suggest that the variability in virulence among these 
Mtb strains affects the capacity of leukocytes to respond 
to pathogenic challenge and mount an immune response 
against it, highlighting important parallels from stud-
ies performed in mouse models. The association of the 
observed effects in this study and specific virulence 
factors previously described for Mtb warrant further in-
vestigation. We support the notion that our Mtb clinical 
isolate strains make good candidates for further investi-
gation using genome sequencing, transcriptome hybridi-
sation, and comparative proteomics, probably leading to 
the eventual identification of Mtb genes associated with 
virulence and the interference of human DC biological 
functions, as previously proposed.(13)
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